PharmaEngine Inc banner
P

PharmaEngine Inc
TPEX:4162

Watchlist Manager
PharmaEngine Inc
TPEX:4162
Watchlist
Price: 58.2 TWD -1.36% Market Closed
Market Cap: NT$8.5B

Wall St Price Targets

Price Targets Summary
PharmaEngine Inc

There are no price targets for PharmaEngine Inc.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
PharmaEngine Inc Competitors:
Price Targets
NWSA
News Corp
21% Upside
CREX
Creative Realities Inc
186% Upside

Revenue
Forecast

13% / Year
Past Growth
82% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
13% / Year
Past Growth
82% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 2 years is 82%.

Gross Profit
Forecast

13% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
13% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 1 year is 6%.

Operating Income
Forecast

18% / Year
Past Growth
141% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
18% / Year
Past Growth
141% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 2 years is 141%.

Pre-Tax Income
Forecast

20% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
20% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 1 year is 2%.

Net Income
Forecast

17% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
17% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 1 year is 7%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PharmaEngine Inc's stock price target?
Not Available

PharmaEngine Inc does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for PharmaEngine Inc?
Projected CAGR
82%

Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 2 years is 82%.

What is the Gross Profit forecast for PharmaEngine Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 1 year is 6%.

What is the Operating Income forecast for PharmaEngine Inc?
Projected CAGR
141%

Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 2 years is 141%.

What is the Pre-Tax Income forecast for PharmaEngine Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 1 year is 2%.

What is the Net Income forecast for PharmaEngine Inc?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 1 year is 7%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett